-
CHAMPALIMAUD FOUNDATION:TIL-WORKSHOP, APRIL 24th-25th, 2024
Visit the Champalimaud TIL workshop (Tumor Infiltrating Lymphocytes) for the treatment of patients with solid cancers. For more information click here >>>
-
APV SEMINAR, MAY 14th-15th, 2024
The seminar will cover biopharma stability and cold stability for biologics/therapeutic proteins, with topics such as mechanisms of freezing, control of freezing & thawing, modelling, equipment, stabilisation by excipients, R&D strategies and alternative methods.
Further information and the registration form can be found here. >>>
-
DG-GT ANNUAL MEETING, MARCH 6th-8th, 2024
The DG-GT e.V. brings together scientists and clinicians who are involved in the most diverse areas of vector development, gene transfer techniques, gene therapy treatment strategies and their implementation in the clinic. More information can be found here >>>
-
GMP PHARMA CONGRESS, MARCH 20th, 2024
As a part of the GMP Pharma Congress, you can look forward to an exciting presentation by our Senior GMP Project Manager Dr Carsten Börger in collaboration with Frank Hesseler from Schlafender Hase. The topic of the presentation is the ,,Development and validation of a cloud-based system for automated text verification''. Information and registration form can be found here. >>>
-
CULT.TAINER WEB SESSION, JANUARY 30th, 2024
In this webinar, we will introduce the cult.tainer® concept, a turnkey production solution for GMP-compliant iATMPs. For further details and the registration formular, click here. >>>
-
VIRTUAL LECTURES GMP-BASICS I-III, NOVEMBER 3 & 4 & 24, 2023
The lecture by Dr. Hans-Georg Eckert, Managing Director and Senior Consultant of Valicare GmbH, will take place as part of the Master's Course MSc Bioanalytical Chemistry and Pharmaceutical Analysis at Fresenius University in Idstein. The three virtual training modules will be offered free of charge via Zoom. For further details and the access link, please click here. >>>
-
ISPE-ATMP SEMINAR, NOVEMBER 20 & 21, 2023
An ISPE DACH ATMP seminar focusing on aseptic processing technologies in the pharmaceutical industry. The event will include a tour of the Robert Bosch Hospital. More details about the event can be found on the linked website. >>>
-
7TH CELL THERAPY SYMPOSIUM, NOVEMBER 3 & 4, 2023
We are excited to be part of this year's 6th Cell Therapy Symposium at Heidelberg University Hospital. This symposium serves as a platform for the latest advancements in cell therapy.
>>>
Welcome to Valicare!
GMP for manufacturers in pharma, biotech, medical devices & ATMPs.
We have been offering a broad spectrum of classical and special GMP services for over 20 years now. Our GMP experts will advise and support you.
Learn moreATMP news from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Here Is Why Killer T Cells in Solid Tumors Lose Energy, According to Research
23.03.2024 | World NewsAs powerful as T cells may be, current research has revealed that once they enter the environment of a solid tumour, they lose the energy ...
CGTLive®’s Weekly Rewind – March 22, 2024
22.03.2024 | CGTLiveReview top news and interview highlights from the week ending March 22, 2024.
New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy
22.03.2024 | Medical XpressChimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified ...
Wie sich die moderne Wirkstoffentwicklung auf Wissenschaft, Lehre und Gesellschaft auswirkt
22.03.2024 | Deutsche Apotheker Zeitung onlineEin Credo des Curriculums für das Pharmaziestudium ist stets, dass man nicht nur für die ...
The Role of Lasers in 3D Printing Organs: Innovations and Implications
22.03.2024 | AZoOpticsThe number of patients with organ failure has increased significantly, consequently driving up the demand for organ transplants worldwide. ...
First-reported fully vascularised organoids on chip
22.03.2024 | Electronic SpecifierThe Interdisciplinary Research Institute of Grenoble (CEA-Irig), CEA-Leti and fellow European and Canadian institutes and researchers have ...
Immuntherapie gegen resistenten Blutkrebs wirkt wieder
22.03.2024 | Moneycab.comZürich – Weisen Krebszellen einer aggressiven Blutkrebsart eine bestimmte Mutation auf, wirken neuartige Immuntherapien wie die CAR T-Zell- ...
‘Dramatic and rapid’ regression of glioblastoma after next generation CAR-T therapy
21.03.2024 | Bionity.COMResearchers took a new approach to CAR-T, engineering CAR-TEAM cells to treat mixed ...
Das Krebsarzneimittel-Paradoxon
21.03.2024 | Deutsche Apotheker Zeitung onlineDer Umgang des Gesetzgebers mit Krebsarzneimitteln ist paradox: Auf der eine Seite hat er die ...
Around the Helix: Cell and Gene Therapy Company Updates – March 20, 2024
20.03.2024 | CGTLiveCatch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
KI entwickelt Antikörper
20.03.2024 | CIOAuf der Suche nach neuen Antikörper-Behandlungen, um schwere Krankheiten zu bekämpfen, setzt Boehringer Ingelheim ...
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma
19.03.2024 | Medical XpressThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19- ...
Spin-off der Universitätsmedizin Mainz ActiTrexx behandelt ersten Patienten mit neuartiger Zelltherapie gegen Graft-versus-Host Disease
19.03.2024 | DeutschesGesundheitsPortal... – Phase-Ib/II-Studie mit Actileucel, einem neuartigen Zellprodukt, das aktivierte regulatorische T-Zellen zur ...
UV-damaged RNA in daughter cells captured by stress granules
18.03.2024 | NewsBeezerCells inherit protection from one of the sun’s overlooked damages – UV-damaged RNA. Although the damage from UV-damaged RNA is not as well ...
FDA Approves First Gene Therapy for Children with Metachromatic Leukodystrophy
18.03.2024 | FDAFor Immediate Release: March 18, 2024 ...
Valicare – competent, reliable & efficient
You have little time and still want to know what services Valicare GmbH offers?